$MRK Recent Headlines Planned layoffs up 13.5% in

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 11:41 PM

$MRK Recent Headlines

Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 profit falls to $1.12 bln vs. $1.73 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 EPS falls to $0.38 from $0.56 year ago 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Small caps surge, the year's best trading day and R.I.P. Lou Reed 6:37 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
The next big pharma 7:01 a.m. Oct. 25, 2013 - The Trading Deck

4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Today - Seeking Alpha
Can U.S. Add Two Million Jobs This Year? 6:08 a.m. Today - 247WallSt.com
Merck Looks Like a Relative Bargain 6:00 a.m. Today - TheStreet.com
10-Q: MERCK & CO. INC. 5:02 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Gilead Vs. Challengers In The Hepatitis C Race 7:00 a.m. Nov. 7, 2013 - Seeking Alpha
Boeing Will Make Key 777X Parts in Seattle and 2 Other Dow Movers to Watch 1:14 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Earnings Beat at Hospira in Q3, View maintained - Analyst Blog 12:27 p.m. Nov. 6, 2013 - Zacks.com
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Nov. 6, 2013 - Zacks.com
Merck & Co Inc's Buy Recommendation Affirmed 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Bristol-Myers Not Done Climbing 6:30 a.m. Nov. 6, 2013 - TheStreet.com
Cramer's Lightning Round - Alcoa Is Creeping Up (11/5/13) 6:09 a.m. Nov. 6, 2013 - Seeking Alpha
'Mad Money' Lightning Round: ConocoPhillips Is Terrific 5:45 a.m. Nov. 6, 2013 - TheStreet.com
7 Generous Dividend Stocks Giving Big Cash Back to Shareholders 1:00 a.m. Nov. 6, 2013 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Got Growth? 8:27 p.m. Nov. 5, 2013 - TheStreet.com
3M Finalizes Asian Investments to Support Window Film and 2 Other Dow Movers to Watch 4:56 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Here’s How Pharma Stocks Are Outperforming the S&P 500 1:31 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
Insider Trading Alert - OPK, ALGN, AREX, IBKR And MRK Traded By Insiders 2:10 p.m. Nov. 4, 2013 - TheStreet.com
DoJ Wants Divestments from US Airways, Amazon Preps ‘Alpha House,’ and 3 More Hot Stocks 12:58 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet

Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes 12:00 p.m. Today - PR Newswire
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director 9:00 a.m. Today - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Merck Animal Health Launches Global Awareness Campaign to Support Pet Diabetes Month(TM) 6:42 p.m. Nov. 5, 2013 - PR Newswire
Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors 5:01 p.m. Nov. 5, 2013 - PR Newswire
InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite(R) Patents in Patent Infringement Lawsuit 4:36 p.m. Nov. 5, 2013 - BusinessWire
Codexis Appoints Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development 4:01 p.m. Nov. 5, 2013 - BusinessWire
Surprising Earnings and News Updates: General Motors, BlackBerry, American International Group, First Solar, Merck & Co. 1:55 p.m. Nov. 4, 2013 - PR Newswire
Fitch: Pharmaceutical Cost Cutting Still Includes R&D for Some 11:18 a.m. Nov. 4, 2013 - BusinessWire
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix 8:00 a.m. Nov. 4, 2013 - PR Newswire
Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 7:30 a.m. Nov. 4, 2013 - BusinessWire
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:00 a.m. Nov. 2, 2013 - BusinessWire
Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis 9:00 a.m. Oct. 31, 2013 - PR Newswire
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer 1:15 a.m. Oct. 29, 2013 - BusinessWire
NQ, FIO, MRK and PBR added to NYSE Active Stock Watch List at GSR 10:55 a.m. Oct. 28, 2013 - ACCESSWIRE
EMD Serono and Open Monoclonal Technology Expand Collaboration to Include Unlimited Access to OmniRat(R) Human Antibody Platform 8:00 a.m. Oct. 28, 2013 - BusinessWire
Merck Announces Third-Quarter 2013 Financial Results 7:00 a.m. Oct. 28, 2013 - BusinessWire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:49 a.m. Oct. 28, 2013 - GlobeNewswire
ABLYNX TO PRESENT PRE-CLINICAL PROOF-OF-CONCEPT DATA ON ALX-0761 AT ACR 2:30 a.m. Oct. 28, 2013 - Thomson Reuters ONE
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Workforce Transformation: Zellis Connect 2026

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Fosun Pharma Hits the Buyback Button: What's Next?

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Nuix Leverages AI for Transformative Legal Review

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

XiamenAir Takes Off with Fujian-London Link

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

BYD's Chip Mastery Amid China's Auto Supply Tensions

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

PBC 2026 Forum: Philanthropic Titans Collide in HK

A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...

SKF's Automotive Arm Set for Stockholm Debut in Dec

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

La Compagnie Unveils NYC-Düsseldorf Flight Plans

A new chapter is unfolding in the skies over the Atlantic. La Compagnie is gearing up to connect New York to Düsseldorf with a direct, all-business-class flight starting in Spring 2027. This move is ambitious, tapping into the bustling economic energy present across the North Rhine-Westphalia region—an economic powerhouse littered with U.S.-affiliated businesses. A...

Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...